A team of Spanish researchers, with the participation of Noelia Ferruz from the IBMB, will design proteins using AI to make advanced therapies more efficient.

The project will be undertaken by a public-private consortium formed by VIVEbiotech, Integra Therapeutics and OneChain Immunotherapeutics, the UPF, the IBMB-CSIC and the CIEMAT over the next four years. The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation (CDTI) have selected it as one of the 40 projects that address a challenge that is at the forefront of society and the economy, and which will be funded by €3.8 million.

Source: UPF